B
Bertram Pitt
Researcher at University of Michigan
Publications - 834
Citations - 88351
Bertram Pitt is an academic researcher from University of Michigan. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 107, co-authored 754 publications receiving 78458 citations. Previous affiliations of Bertram Pitt include Rutgers University & Tufts Medical Center.
Papers
More filters
Journal ArticleDOI
Heart failure: the role for mineralocorticoid receptor antagonists.
TL;DR: Application of current guidelines recommended therapies, including MRA's hold the best promise to further reduce cardiovascular mortality, hospitalisations for heart failure, and therefore, health care costs in patients with heart failure.
Journal ArticleDOI
Unstable Angina: Morbidity and mortality in fifty-seven consecutive patients evaluated angiographically
Journal ArticleDOI
Teasing Apart Heart Failure With Preserved Ejection Fraction Phenotypes With Echocardiographic Imaging: Potential Approach to Research and Clinical Practice.
Edgar Argulian,Y S Chandrashekhar,Sanjiv J. Shah,Olivier Huttin,Bertram Pitt,Faiez Zannad,Robert O. Bonow,Jagat Narula +7 more
TL;DR: The existing phenotyping approach to heart failure is based on the premise of LVEF as a surrogate marker for left ventricular systolic performance and, in turn, prognosis.
Journal ArticleDOI
ACE inhibitors for myocardial infarction and unstable angina
Salim Yusuf,Salim Yusuf,Salim Yusuf,John B. Kostis,John B. Kostis,John B. Kostis,Bertram Pitt,Bertram Pitt,Bertram Pitt +8 more
TL;DR: In basements, the respective medians were higher by a factor of 2-3 than on the ground floor than in the UK, and the maximum amount measured was 274 000 Bq/m3.
Journal ArticleDOI
Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function
Iris E. Beldhuis,Peder L. Myhre,Michael R. Bristow,Brian Claggett,Kevin Damman,James C. Fang,Jerome L. Fleg,Sonja M. McKinlay,Eldrin F. Lewis,Eileen O'Meara,Bertram Pitt,Sanjiv J. Shah,Orly Vardeny,Adriaan A. Voors,Marc A. Pfeffer,Scott D. Solomon,Akshay S. Desai +16 more
TL;DR: The TOPCAT-Americas study as discussed by the authors showed that spironolactone-associated worsening renal function (WRF) increased the risk of heart failure hospitalization and all-cause mortality.